Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Author(s) -
Fernando P. Polack,
Stephen J. Thomas,
Nicholas Kitchin,
Judith Absalon,
Alejandra Gurtman,
Stephen Lockhart,
John L. Perez,
Gonzalo Pérez Marc,
Edson Duarte Moreira,
Cristiano A. F. Zerbini,
Ruth Bailey,
Kena A. Swanson,
Satrajit Roychoudhury,
Kenneth Koury,
Ping Li,
Warren V. Kalina,
David Cooper,
Robert W. Frenck,
Laura L Hammitt,
Özlem Türeci,
Haylene Nell,
Axel Schaefer,
Serhat Ünal,
Dina B Tresnan,
Susan Mather,
Philip R. Dormitzer,
Uǧur Şahin,
Kathrin U. Jansen,
William C. Gruber
Publication year - 2020
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2034577
Subject(s) - covid-19 , virology , business , medicine , outbreak , infectious disease (medical specialty) , disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom